The US National Institutes of Health has agreed to increase the royalty payments to the Institute Pasteur in France relating to sales of HIV testing kits. The decision marks the first time that the US government has acknowledged the fact that NIH researcher Robert Gallo used a virus from Institut Pasteur when he developed a blood test for the virus.
Under the new agreement, the NIH and Pasteur will keep the first 20% of royalties from the kit. Of the remaining royalties, 50% will go to Pasteur, 25% will go to the NIH and the remaining 25% will go to the World AIDS Foundation.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze